|Bid||16.80 x 1000|
|Ask||18.33 x 1800|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||21.35|
Yahoo Finance's Julie Hyman, Adam Shapiro, Brian Cheung, and Ethan Wolff-Mann join Avantor CEO and President Michael Stubblefield.
Fans of initial public offerings (IPOs) have gotten one flashy deal after another in 2019. Some companies such as Beyond Meat (BYND) shocked onlookers with a meteoric ascent, while other hotly hyped companies such as Uber Technologies (UBER) crashed and burned early on. But broadly speaking, there's demand for IPOs, and up-and-coming companies are happy to fill that demand."IPO activity is (mildly) cyclical, as management teams take the opportunity to go public while being buoyed by favorable economic conditions," Bernstein equity strategist Noah Weisberger told CNBC in explaining this year's red-hot IPO market.It's early going for these new stocks, however. They have only a few months of trading under their belts, and very little financial track record to go on. With so little information at their fingertips, investors must rely heavily on Wall Street's analysts for insights into the comings and goings of these IPOs.Here are 10 recent higher-profile IPOs, and what analysts are saying about each of these new stocks. SEE ALSO: The 19 Best Stocks to Buy for the Rest of 2019
Radnor-based chemical and laboratory products supplier Avantor closed its initial public stock offering, which swelled to $3.33 billion after underwriters exercised their full option to purchase additional shares to cover overallotments. Avantor [NYSE: AVTR) ended up selling 238.05 million shares of common stock at $14 per share. This year only Uber's $8.1 billion IPO, completed earlier this month, was larger.
RADNOR, Pa. , May 21, 2019 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, ...
Chemicals company Avantor (NYSE: AVTR ) made its debut on the New York Stock Exchange Friday morning. Avantor issued 205 million shares priced at $14. Avantor shares opened for trade 11:10 a.m. at $14.72. ...
Chemicals company Avantor Inc. shares rose 4.5% in their trading debut Friday, after underwriters priced the company's initial public offering at $14 a share, the low end of its range. The company sold 207 million shares to raise $2.9 billion. The company also offered 18 million shares of its 6.252% Series A mandatory convertible preferred stock at $50 a share. The company will use the proceeds of the deal to redeem all of its existing Series A preferred stock and to repay some of its senior secured term loans. The common stock and preferred stock are trading on the New York Stock Exchange under the ticker symbols "AVTR" and "AVTR PRA." Goldman Sachs and JPMorgan were lead underwriters on the dal with another 24 banks participating. Avantor makes products for the biopharma, health care, education and government and advanced tech industries. The company is mostly made up of VWR, which was taken private by private-equity firm New Mountain and Goldman Sachs in 2017. The company has more than $7 billion in debt.
RADNOR, Pa., May 16, 2019 /PRNewswire/ -- Avantor, Inc. ("Avantor"), a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries, announced today that it has priced the initial public offering of 207,000,000 shares of its common stock at a price to the public of $14.00 per share and a concurrent public offering of 18,000,000 shares of its 6.250% Series A Mandatory Convertible Preferred Stock (the "Mandatory Convertible Preferred Stock") at a price to the public of $50.00 per share. Avantor intends to use a portion of the net proceeds received from the offerings to redeem all outstanding shares of its existing Series A Preferred Stock and use the remaining proceeds to repay a portion of its outstanding indebtedness under its senior secured term loan facilities. The completion of the offering of Mandatory Convertible Preferred Stock is contingent upon the completion of the offering of common stock.
The Street lends plenty of exposure to various medical developments. But one company will soon offer exposure to the broad biotech industry. The IPO Avantor, Inc. will issue 154 million shares on the New ...